Want to track VRCA and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Verrica Pharmaceuticals Inc. (VRCA) Statistics
Valuation metrics
Market Cap 97.75M
Enterprise value 88.36M
Trailing P/E (ttm) -3.27
Forward P/E -3.71
PEG ratio -0.09
Price/Sales (ttm) 3.22
Price/Book (mrq) 28.15
Enterprise Value/Revenue 2.91
Enterprise Value/EBITDA -3.29
Overview
Shares outstanding 17.18M
Float 6.78M
Shares short 497.75K
% Held by insiders 0.48%
% Held by institutions 0.3%
Average volume (10 days) 350.76K
Average volume (90 days) 94.95K
Price summary
52-Week low 3.28
52-Week high 9.82
Beta 1.43
50-Day moving average 5.18
200-Day moving average 5.97
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:10
Last split Date 25 Jul 2025
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Dec 2025
Profitability
Profit margin -1.03%
Operating margin -0.93%
Operational effectiveness
Return on assets -0.87%
Return on equity -4.44%
Income Statement
Revenue (ttm) 35.58M
Revenue per share (ttm) 1.42
Quarterly revenue growth (yoy) 13.8%
Gross profit (ttm) 23.28M
EBITDA -11.45M
Net income to common (ttm) -17.89M
Diluted EPS (ttm) -1.46
Quarterly earnings growth (yoy) 13.8%
Balance Sheet
Total cash (mrq) 30.15M
Total cash per share (mrq) 0.53
Total debt (mrq) 1.63M
Total Debt/Equity (mrq) 0.42
Current ratio (mrq) 1.45%
Book value per share (mrq) 0.2
Cash Flow
Cash flow statement -17.63M
Levered free cash flow (LFCF) -15.46M
